tradingkey.logotradingkey.logo
優惠
Tradingkey

Windward Bio Group Ord Shs

WWB
添加自選
24.285USD
+0.275+1.15%
收盤 11-20 16:00(美東)
0.00總市值
--本益比TTM

Windward Bio Group Ord Shs

24.285
+0.275+1.15%

關於 Windward Bio Group Ord Shs 公司

Windward Bio AG is a Switzerland-based company primarily engaged in the biotechnology and biopharmaceutical industry. The Company focuses on the development of ultra-long-acting antibody medicines for immunological, respiratory, and dermatologic diseases, including asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis. Their key product is WIN378, which is a monoclonal antibody therapeutic that targets thymic stromal lymphopoietin (TSLP). It aims to reduce inflammation associated with respiratory diseases and provide longer dosing intervals for patients. The Company is also developing WIN027, a bispecific antibody targeting TSLP and interleukin-13 (IL-13) for immunological disorders.

Windward Bio Group Ord Shs 簡介

公司代碼WWB
公司名稱Windward Bio AG
上市日期Nov 13, 2026
CEOSantarelli (Luca)
員工數量- -
證券類型Ordinary Share
年結日- -
公司地址Aeschenplatz 6
城市BASEL
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Switzerland
郵編4052
電話41615517575
網址https://windwardbio.com/
公司代碼WWB
上市日期Nov 13, 2026
CEOSantarelli (Luca)

Windward Bio Group Ord Shs公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Luca Santarelli, M.D.
Mr. Luca Santarelli, M.D.
Founder, Chief Executive Officer, Board Chair
Founder, Chief Executive Officer, Board Chair
--
--
Mr. Michael Steininger
Mr. Michael Steininger
Head of Human Resources
Head of Human Resources
--
--
Ms. Martine Mazzetti, Ph.D.
Ms. Martine Mazzetti, Ph.D.
Chief of Staff
Chief of Staff
--
--
Ms. Claudia D'augusta, Ph.D.
Ms. Claudia D'augusta, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Scott Applebaum
Mr. Scott Applebaum
Chief Legal, Business Officer
Chief Legal, Business Officer
--
--
Mr. Omar Khwaja, M.D., Ph.D.
Mr. Omar Khwaja, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Kevin Harris
Mr. Kevin Harris
Chief Operating Officer
Chief Operating Officer
960.97K
--
Mr. Luca Santarelli, M.D.
Mr. Luca Santarelli, M.D.
Founder, Chief Executive Officer, Board Chair
Founder, Chief Executive Officer, Board Chair
--
--
Mr. Michael Steininger
Mr. Michael Steininger
Head of Human Resources
Head of Human Resources
--
--
tradingkey.logotradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有